4//SEC Filing
Lim Bryant David 4
Accession 0001562180-24-008532
CIK 0001678660other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 7:35 AM ET
Size
5.4 KB
Accession
0001562180-24-008532
Insider Transaction Report
Form 4
Lim Bryant David
CLO, CFO, Corp Sec.
Transactions
- Purchase
Common Stock
2024-12-19$0.91/sh+25,000$22,638→ 27,400 total
Footnotes (1)
- [F1]1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.87 to $0.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
Documents
Issuer
Prelude Therapeutics Inc
CIK 0001678660
Entity typeother
Related Parties
1- filerCIK 0001752888
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 7:35 AM ET
- Size
- 5.4 KB